Pomerantz To Lead Lexicon Pharmaceuticals Securities Suit
A Texas federal judge has ordered the Pomerantz Law Firm to serve as lead counsel in shareholders' proposed class action accusing Lexicon Pharmaceuticals of promising more than it could deliver in...To view the full article, register now.
Already a subscriber? Click here to view full article